| A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis | neurotrophic keratopathy | Recruiting | Phase 2 | 2026-09-25 | | NCT07568730 |
|---|
| Clinical Predictors of Visual Outcome in Patients Affected With Ocular Surface Diseases | corneal disorder, eye disorder, keratitis, limbal stem cell deficiency, neurotrophic keratopathy | Not yet recruiting | Not stated | 2026-07-14 | | NCT07694817 |
|---|
| Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy | neurotrophic keratopathy | Recruiting | Not applicable | 2026-05-06 | | NCT04604834 |
|---|
| A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis | neurotrophic keratopathy | Recruiting | Phase 2 | 2026-04-07 | | NCT06975748 |
|---|
| A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis | neurotrophic keratopathy | Recruiting | Phase 1 / Phase 2 | 2026-02-27 | | NCT06999733 |
|---|
| Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 | neurotrophic keratopathy | Recruiting | Phase 3 | 2025-12-23 | | NCT05555589 |
|---|
| Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study | neurotrophic keratopathy | Not yet recruiting | Not applicable | 2025-07-18 | | NCT07073729 |
|---|
| Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease | autoimmune disease, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder, neurotrophic keratopathy | Recruiting | Phase 4 | 2025-05-11 | | NCT06964269 |
|---|
| DOMPE -MT Neurotrophic Keratitis | dry eye syndrome, eye disorder, lacrimal apparatus disorder, neurotrophic keratopathy | Active, not recruiting | Phase 4 | 2025-04-27 | | NCT06947850 |
|---|
| Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis | neurotrophic keratopathy | Recruiting | Phase 2 | 2024-10-28 | | NCT05927428 |
|---|